Treatment of Obstructive Sleep Apnea (OSA) With the da Vinci® SP™ Surgical System
A Prospective Single Center Investigation of the da Vinci® SP™ Surgical System for Transoral Robotic Surgery (TORS) for Treatment of Obstructive Sleep Apnea (OSA)
1 other identifier
observational
25
1 country
1
Brief Summary
It is a prospective, single center, single-arm clinical study to enroll a maximum of 25 subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 27, 2021
CompletedFirst Submitted
Initial submission to the registry
February 1, 2021
CompletedFirst Posted
Study publicly available on registry
March 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 25, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 25, 2023
CompletedMay 31, 2023
May 1, 2023
2 years
February 1, 2021
May 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Type 1 Polysomnography (PSG)
Type I PSG measurements demonstrating Apnea Hypopnea Index (AHI) reduction.
Pre-operative (within 12 months prior to surgery)
Type 1 Polysomnography (PSG)
Type I PSG measurements demonstrating Apnea Hypopnea Index (AHI) reduction.
90-150 days after surgery
Secondary Outcomes (19)
Total operative time
Intra-Operative Assessment
Robotic procedure time
Intra-Operative Assessment
Estimated blood loss (EBL)
Intra-Operative Assessment
Postoperative hemorrhage
Intra-Operative Assessment
Blood transfusions
Intra-Operative Assessment
- +14 more secondary outcomes
Study Arms (1)
Single arm
Subjects will undergo TORS benign base of tongue resection procedures (i.e., partial glossectomy, epiglottoplasty, epiglottectomy, and/or lingual tonsillectomy) for the treatment of OSA
Interventions
Subjects will undergo TORS benign base of tongue resection procedures (i.e., partial glossectomy, epiglottoplasty, epiglottectomy, and/or lingual tonsillectomy) for the treatment of OSA. Concomitant non-robotic surgical procedures may also be performed as part of the subject's treatment for OSA, and can include one or more of the following: uvulopalatopharyngoplasty (UPPP), lateral pharyngoplasty, expansion sphincter pharyngoplasty, palatine tonsillectomy, or a modified uvulopalatoplasty. Nasal surgery such as septoplasty or turbinoplasty can be combined if it is needed.
Eligibility Criteria
* Subject who has failed or is unable to tolerate CPAP therapy * Subject who is diagnosed with OSA due to redundant base of tongue tissue * Subject who has moderate to severe sleep apnea, defined as 15 or more AHI events/hour * Subject who has planned a tongue base resection surgery
You may qualify if:
- Subject is between 18 and 80 years old
- Subject with BMI ≤ 35
- Subject with moderate to severe sleep apnea, defined as 15 or more AHI events/hour
- Subject who has failed or is unable to tolerate CPAP therapy
- Subject diagnosed with OSA due to redundant base of tongue tissue
- Subject must be a suitable candidate for base of tongue resection surgery
- Subject who is willing and able to provide written informed consent
- Subject who is willing and able to comply with the study protocol requirements
You may not qualify if:
- Subject with a poor mouth opening or trismus
- Subject with evidence of any primary cancers or metastatic disease, other than skin cancers
- Subject who has had a surgical resection and/or chemoradiation therapy for oropharyngeal cancer
- Subject with congenital malformations in the larynx, throat or tongue
- Subject with an American Society of Anesthesiologists (ASA) score of Grade 4 or above during preoperative evaluation
- Subject for whom any additional surgeries are planned for OSA within the study period, after the surgery in which the da Vinci SP System was used
- Subject who is mentally handicapped or with a psychological disorder or severe systemic illness, that would preclude compliance with study requirements or ability to provide informed consent
- Subject is pregnant or suspected to be pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Severance Hospital, Yonsei University Health System
Seoul, 03722, South Korea
Related Publications (1)
Jeong Y, Rha MS, Kim CH, Cho HJ. First Prospective Study on Single-Port Robotic Tongue Base Resection for Sleep Apnea. Head Neck. 2025 Apr;47(4):1071-1078. doi: 10.1002/hed.28007. Epub 2024 Nov 22.
PMID: 39576059DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
HyungJu Cho, M.D., Ph.D.
Severance Hospital, Yonsei University Health System
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 1, 2021
First Posted
March 12, 2021
Study Start
January 27, 2021
Primary Completion
January 25, 2023
Study Completion
January 25, 2023
Last Updated
May 31, 2023
Record last verified: 2023-05